RNPC3 and chronic myelogenous leukemia, BCR-ABL1 positive: CML patient-derived PBMCs electroporated with RNP complexes demonstrated best performance of CCExo in comparison to other tested variants (Fig. 4d, Supplementary Fig. 23).